RAFAEL TABARES SEISDEDOS-rekin lankidetzan egindako argitalpenak (97)

2024

  1. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

    The Lancet, Vol. 403, Núm. 10440, pp. 2162-2203

  2. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

    The Lancet Neurology, Vol. 23, Núm. 4, pp. 344-381

  3. Global, regional, and national burden of injuries, and burden attributable to injuries risk factors, 1990 to 2019: results from the Global Burden of Disease study 2019

    Public Health, Vol. 237, pp. 212-231

  4. Risk of cancer development associated with disease-modifying therapies for multiple sclerosis: study protocol for a systematic review and meta-analysis of randomised and non-randomised studies

    Systematic reviews, Vol. 13, Núm. 1, pp. 263

2023

  1. A cross-sectional analysis identified co-authorship networks and scientific collaboration on reporting guidelines for health research

    Journal of Clinical Epidemiology, Vol. 157, pp. 22-34

  2. Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026

    The Lancet Global Health, Vol. 11, Núm. 3, pp. e385-e413

  3. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

    The Lancet, Vol. 402, Núm. 10397, pp. 203-234

2022

  1. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019

    The Lancet Global Health, Vol. 10, Núm. 12, pp. e1715-e1743

  2. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019

    JAMA Oncology, Vol. 8, Núm. 3, pp. 420-444

  3. Design and methodological characteristics of studies using observational routinely collected health data for investigating the link between cancer and neurodegenerative diseases: protocol for a meta-research study

    BMJ open, Vol. 12, Núm. 4, pp. e058738

  4. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

    The Lancet Public Health, Vol. 7, Núm. 2, pp. e105-e125

  5. Mortality in Persons with Autism Spectrum Disorder or Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis

    JAMA Pediatrics, Vol. 176, Núm. 4, pp. E216401

  6. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019

    The Lancet Oncology, Vol. 23, Núm. 1, pp. 27-52

2021

  1. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019

    Alzheimer's and Dementia: Translational Research and Clinical Interventions, Vol. 7, Núm. 1

  2. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019

    The Lancet, Vol. 398, Núm. 10311, pp. 1593-1618

  3. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050

    The Lancet, Vol. 398, Núm. 10308, pp. 1317-1343

  4. Use of multidimensional item response theory methods for dementia prevalence prediction: an example using the Health and Retirement Survey and the Aging, Demographics, and Memory Study

    BMC Medical Informatics and Decision Making, Vol. 21, Núm. 1

2020

  1. Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017

    Injury Prevention, Vol. 26, pp. T12-I26

  2. Estimating global injuries morbidity and mortality: Methods and data used in the Global Burden of Disease 2017 study

    Injury Prevention, Vol. 26, Núm. 1, pp. I125-I153

  3. Five insights from the Global Burden of Disease Study 2019

    The Lancet, Vol. 396, Núm. 10258, pp. 1135-1159